German Firm Buys 15 Consumer Healthcare Brands from GSK

German pharmaceutical firm Stada AG entered into an agreement to purchase 15 of GlaxoSmithKline’s (GSK) local and regional consumer healthcare brands, expanding its portfolio of OTC products, a company announcement said Monday. 

“The brands being acquired, and their geographic presence, are well aligned with Stada’s core countries and our organic activities,” the firm’s chief executive officer, Peter Goldschmidt, said in a press release.” This will enable us to drive additional growth alongside our strong growth in the generics business. Under our ownership, we believe there is an excellent opportunity to revitalize and grow these consumer healthcare brands.”

The sale includes Venorution brand products used for venous treatment, Coldrex cold remedy products, Cetebe vitamin C supplements, the Tavegyl allergy brand, and Mebucaine products for treatment of sore throats. Sales of these brands in Germany, Russia, Poland, and Spain make up about 10% of turnover in GSK’s Consumer Healthcare portfolio. 

Click here for information about the upcoming International Powder & Bulk Solids Conference/Exhibition

Last year, Stada purchased five OTC skincare brands from GSK – Ceridal, Eurax, Oilatum, Polytar, and Savlon – and the Tixylix brand of pediatric cough remedies in Europe and certain markets in Asia-Pacific and Latin America. 

Earlier this month, Powder & Bulk Solids reported that GSK is shutting a manufacturing plant in Carlisle, PA that produces Emergen-C powdered supplement drink mixes by mid-2021. The company plans to shift manufacturing of the product to a facility in Puerto Rico. 

For more news headlines, articles, and equipment reviews, visit our Equipment Zones

More Powder & Bulk Solids articles:

Massive Blaze Sparked at ExxonMobil Facility

Conveying Equipment Orders Soar 235%

Kice Industries Names New VP of Sales